Search

Search Constraints

You searched for: Author/Creator Clavell, Luis A.

Search Results

1. An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001. Issue 3 (1st November 2017)

2. Corrigendum. Issue 3 (31st December 2020)

3. Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001. Issue 31 (1st November 2021)

4. Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort. Issue 6 (December 2019)

5. Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001. Issue 1 (7th October 2020)

6. Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001. Issue 1 (7th October 2020)

7. Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemia. Issue 19 (16th July 2013)

8. Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemia. Issue 19 (16th July 2013)

9. Outcome of children and adolescents with Down syndrome treated on Dana‐Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00–001 and 05‐001. Issue 10 (7th June 2018)

10. Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001. Issue 8 (22nd March 2022)